Keyword Search
Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: oncology returned 20 record(s)
|
|
Tuesday, 08/01/2017
|
Dose Finding in Oncology Trials: a Discussion on Challenges and Current Methods
Zhao Yang, Amgen, Inc.
|
Maintaining Trial Integrity for Randomized Open-Label Trials
Wenyun Ji, Amgen, Inc.
|
Maintaining Trial Integrity for Randomized Open-Label Trials
Wenyun Ji, Amgen, Inc.
9:05 AM
|
PRO-CTCAE Implementation in Oncology Clinical Trials: An Industry Perspective
Paivi Miskala, Pfizer Inc
2:25 PM
|
PRO-CTCAE in Oncology Clinical Trials: a U.S. Regulatory Perspective
Paul Kluetz, U.S. Food and Drug Administration
2:45 PM
|
Statistical Methods to Analyze PRO-CTCAE Data in Oncology Clinical Trials
Amylou Dueck, Mayo Clinic
3:05 PM
|
|
Wednesday, 08/02/2017
|
Statistical Inference in the Era of Precision Medicine- the Essential Role of Statistics for Unmet Needs in Algorithm Refinement, Diagnostics Application and Drug Development
Ruixiao Lu, Genomic Health
|
Increasing Efficiency of Oncology Basket Trials Using a Bayesian Approach
Zheyu Liu, The University of Texas Health Science Center at Houston; Rong Liu, Bayer Healthcare; Mercedeh Ghadessi, Bayer Healthcare; Richardus.vonk Vonk, Bayer Healthcare
9:05 AM
|
A Case Study Exploration of MTPI and Proposed Methods to Expand to Combination Drug Development
Matthew Gribbin, MedImmune; Nairouz Elgeioushi, MedImmune
10:35 AM
|
Combination Dose Finding in Phase I Oncology Trials: a Co-Data Approach
Niladri Roy Chowdhury, Novartis Oncology Pharmaceuticals; Satrajit Roychoudhury, Pfizer Inc
11:15 AM
|
Practical Considerations on Simulations for Adaptive Dose Escalation and Dose Ranging Trials
Inna Perevozskaya, Glaxo SmithKline; Alun Bedding, Roche UK; Vladimir Dragalin, Janssen R&D; Parvin Fardipour, ICON
2:25 PM
|
Assessing Data Quality of EHR Outcomes: a Case Study from Clinical Oncology
Sandra Griffith, Flatiron Health; Paul You , Flatiron Health; Elizabeth Sweeney, Flatiron Health; Geoff Calkins, Flatiron Health; Amy Abernethy, Flatiron Health
3:05 PM
|
|
|
